• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Expression Competent Cells Market Size, Status and Forecast 2020-2026

report cover
  • 3 September 2020
  • Pharmaceuticals
  • 132 Pages
  • Report Code: 24LS-21409
  • Formate :   
Download FREE Report Sample Download PDF File

Expression Competent Cells -MARKET ADVISORY SERVICES

Global Expression Competent Cells Scope and Market Size
Expression Competent Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Expression Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Chemically Competent Cells
Electrocompetent Cells

Market segment by Application, split into
Protein Expression
Other

Based on regional and country-level analysis, the Expression Competent Cells market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Expression Competent Cells market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expression Competent Cells Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Expression Competent Cells Market Share by Application: 2020 VS 2026
1.3.2 Protein Expression
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Expression Competent Cells Market Perspective (2015-2026)
2.2 Global Expression Competent Cells Growth Trends by Regions
2.2.1 Expression Competent Cells Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Expression Competent Cells Historic Market Share by Regions (2015-2020)
2.2.3 Expression Competent Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Expression Competent Cells Players by Market Size
3.1.1 Global Top Expression Competent Cells Players by Revenue (2015-2020)
3.1.2 Global Expression Competent Cells Revenue Market Share by Players (2015-2020)
3.2 Global Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Expression Competent Cells Revenue
3.4 Global Expression Competent Cells Market Concentration Ratio
3.4.1 Global Expression Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expression Competent Cells Revenue in 2019
3.5 Key Players Expression Competent Cells Area Served
3.6 Key Players Expression Competent Cells Product Solution and Service
3.7 Date of Enter into Expression Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Expression Competent Cells Breakdown Data by Type (2015-2026)
4.1 Global Expression Competent Cells Historic Market Size by Type (2015-2020)
4.2 Global Expression Competent Cells Forecasted Market Size by Type (2021-2026)

5 Expression Competent Cells Breakdown Data by Application (2015-2026)
5.1 Global Expression Competent Cells Historic Market Size by Application (2015-2020)
5.2 Global Expression Competent Cells Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Expression Competent Cells Market Size (2015-2026)
6.2 North America Expression Competent Cells Market Size by Type (2015-2020)
6.3 North America Expression Competent Cells Market Size by Application (2015-2020)
6.4 North America Expression Competent Cells Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Expression Competent Cells Market Size (2015-2026)
7.2 Europe Expression Competent Cells Market Size by Type (2015-2020)
7.3 Europe Expression Competent Cells Market Size by Application (2015-2020)
7.4 Europe Expression Competent Cells Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Expression Competent Cells Market Size (2015-2026)
8.2 China Expression Competent Cells Market Size by Type (2015-2020)
8.3 China Expression Competent Cells Market Size by Application (2015-2020)
8.4 China Expression Competent Cells Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Expression Competent Cells Market Size (2015-2026)
9.2 Japan Expression Competent Cells Market Size by Type (2015-2020)
9.3 Japan Expression Competent Cells Market Size by Application (2015-2020)
9.4 Japan Expression Competent Cells Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Expression Competent Cells Market Size (2015-2026)
10.2 Southeast Asia Expression Competent Cells Market Size by Type (2015-2020)
10.3 Southeast Asia Expression Competent Cells Market Size by Application (2015-2020)
10.4 Southeast Asia Expression Competent Cells Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expression Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expression Competent Cells Business (2015-2020))
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expression Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2015-2020)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expression Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expression Competent Cells Business (2015-2020)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expression Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expression Competent Cells Business (2015-2020)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expression Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expression Competent Cells Business (2015-2020)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expression Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2015-2020)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expression Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expression Competent Cells Business (2015-2020)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expression Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expression Competent Cells Business (2015-2020)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expression Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expression Competent Cells Business (2015-2020)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expression Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expression Competent Cells Business (2015-2020)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
10.11.1 OriGene Technologies Company Details
10.11.2 OriGene Technologies Business Overview
10.11.3 OriGene Technologies Expression Competent Cells Introduction
10.11.4 OriGene Technologies Revenue in Expression Competent Cells Business (2015-2020)
10.11.5 OriGene Technologies Recent Development
11.12 Lucigen
10.12.1 Lucigen Company Details
10.12.2 Lucigen Business Overview
10.12.3 Lucigen Expression Competent Cells Introduction
10.12.4 Lucigen Revenue in Expression Competent Cells Business (2015-2020)
10.12.5 Lucigen Recent Development
11.13 Zymo Research
10.13.1 Zymo Research Company Details
10.13.2 Zymo Research Business Overview
10.13.3 Zymo Research Expression Competent Cells Introduction
10.13.4 Zymo Research Revenue in Expression Competent Cells Business (2015-2020)
10.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
10.14.1 Bio-Rad Laboratories Company Details
10.14.2 Bio-Rad Laboratories Business Overview
10.14.3 Bio-Rad Laboratories Expression Competent Cells Introduction
10.14.4 Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2015-2020)
10.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
10.15.1 Bioline Company Details
10.15.2 Bioline Business Overview
10.15.3 Bioline Expression Competent Cells Introduction
10.15.4 Bioline Revenue in Expression Competent Cells Business (2015-2020)
10.15.5 Bioline Recent Development
11.16 Delphi Genetics
10.16.1 Delphi Genetics Company Details
10.16.2 Delphi Genetics Business Overview
10.16.3 Delphi Genetics Expression Competent Cells Introduction
10.16.4 Delphi Genetics Revenue in Expression Competent Cells Business (2015-2020)
10.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
10.17.1 IBA GmBH Company Details
10.17.2 IBA GmBH Business Overview
10.17.3 IBA GmBH Expression Competent Cells Introduction
10.17.4 IBA GmBH Revenue in Expression Competent Cells Business (2015-2020)
10.17.5 IBA GmBH Recent Development
11.18 Cell Applications
10.18.1 Cell Applications Company Details
10.18.2 Cell Applications Business Overview
10.18.3 Cell Applications Expression Competent Cells Introduction
10.18.4 Cell Applications Revenue in Expression Competent Cells Business (2015-2020)
10.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
10.19.1 BioDynamics Laboratory Company Details
10.19.2 BioDynamics Laboratory Business Overview
10.19.3 BioDynamics Laboratory Expression Competent Cells Introduction
10.19.4 BioDynamics Laboratory Revenue in Expression Competent Cells Business (2015-2020)
10.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
10.20.1 Scarab Genomics Company Details
10.20.2 Scarab Genomics Business Overview
10.20.3 Scarab Genomics Expression Competent Cells Introduction
10.20.4 Scarab Genomics Revenue in Expression Competent Cells Business (2015-2020)
10.20.5 Scarab Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables

Table 1. Global Expression Competent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 3. Key Players of Chemically Competent Cells

Table 4. Key Players of Electrocompetent Cells

Table 5. Global Expression Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 6. Global Expression Competent Cells Market Size by Regions (US$ Million): 2020 VS 2026

Table 7. Global Expression Competent Cells Market Size by Regions (2015-2020) (US$ Million)

Table 8. Global Expression Competent Cells Market Share by Regions (2015-2020)

Table 9. Global Expression Competent Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 10. Global Expression Competent Cells Market Share by Regions (2021-2026)

Table 11. Expression Competent Cells Market Market Trends

Table 12. Expression Competent Cells Market Drivers

Table 13. Expression Competent Cells Market Challenges

Table 14. Expression Competent Cells Market Restraints

Table 15. Global Expression Competent Cells Revenue by Players (2015-2020) (US$ Million)

Table 16. Global Expression Competent Cells Market Share by Players (2015-2020)

Table 17. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expression Competent Cells as of 2019)

Table 18. Global Expression Competent Cells by Players Market Concentration Ratio (CR5 and HHI)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Expression Competent Cells Product Solution and Service

Table 21. Mergers & Acquisitions, Expansion Plans

Table 22. Global Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 23. Global Expression Competent Cells Market Size Share by Type (2015-2020)

Table 24. Global Expression Competent Cells Revenue Market Share by Type (2021-2026)

Table 25. Global Expression Competent Cells Market Size Share by Application (2015-2020)

Table 26. Global Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 27. Global Expression Competent Cells Market Size Share by Application (2021-2026)

Table 28. North America Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 29. North America Expression Competent Cells Market Share by Type (2015-2020)

Table 30. North America Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 31. North America Expression Competent Cells Market Share by Application (2015-2020)

Table 32. North America Expression Competent Cells Market Size by Country (US$ Million) (2015-2020)

Table 33. North America Expression Competent Cells Market Share by Country (2015-2020)

Table 34. Europe Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 35. Europe Expression Competent Cells Market Share by Type (2015-2020)

Table 36. Europe Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 37. Europe Expression Competent Cells Market Share by Application (2015-2020)

Table 38. Europe Expression Competent Cells Market Size by Country (US$ Million) (2015-2020)

Table 39. Europe Expression Competent Cells Market Share by Country (2015-2020)

Table 40. China Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 41. China Expression Competent Cells Market Share by Type (2015-2020)

Table 42. China Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 43. China Expression Competent Cells Market Share by Application (2015-2020)

Table 44. China Expression Competent Cells Market Size by Region (US$ Million) (2015-2020)

Table 45. China Expression Competent Cells Market Share by Region (2015-2020)

Table 46. Japan Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 47. Japan Expression Competent Cells Market Share by Type (2015-2020)

Table 48. Japan Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 49. Japan Expression Competent Cells Market Share by Application (2015-2020)

Table 50. Japan Expression Competent Cells Market Size by Country (US$ Million) (2015-2020)

Table 51. Japan Expression Competent Cells Market Share by Country (2015-2020)

Table 52. Southeast Asia Expression Competent Cells Market Size by Type (2015-2020) (US$ Million)

Table 53. Southeast Asia Expression Competent Cells Market Share by Type (2015-2020)

Table 54. Southeast Asia Expression Competent Cells Market Size by Application (2015-2020) (US$ Million)

Table 55. Southeast Asia Expression Competent Cells Market Share by Application (2015-2020)

Table 56. Southeast Asia Expression Competent Cells Market Size by Country (US$ Million) (2015-2020)

Table 57. Southeast Asia Expression Competent Cells Market Share by Country (2015-2020)

Table 58. Merck KGaA Company Details

Table 59. Merck KGaA Business Overview

Table 60. Merck KGaA Product

Table 61. Merck KGaA Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 62. Merck KGaA Recent Development

Table 63. Thermo Fisher Scientific Company Details

Table 64. Thermo Fisher Scientific Business Overview

Table 65. Thermo Fisher Scientific Product

Table 66. Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 67. Thermo Fisher Scientific Recent Development

Table 68. Agilent Technologies Company Details

Table 69. Agilent Technologies Business Overview

Table 70. Agilent Technologies Product

Table 71. Agilent Technologies Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 72. Agilent Technologies Recent Development

Table 73. Takara Bio Company Details

Table 74. Takara Bio Business Overview

Table 75. Takara Bio Product

Table 76. Takara Bio Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 77. Takara Bio Recent Development

Table 78. Promega Corporation Company Details

Table 79. Promega Corporation Business Overview

Table 80. Promega Corporation Product

Table 81. Promega Corporation Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 82. Promega Corporation Recent Development

Table 83. Beijing TransGen Biotech Company Details

Table 84. Beijing TransGen Biotech Business Overview

Table 85. Beijing TransGen Biotech Product

Table 86. Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 87. Beijing TransGen Biotech Recent Development

Table 88. GeneScript Corporation Company Details

Table 89. GeneScript Corporation Business Overview

Table 90. GeneScript Corporation Product

Table 91. GeneScript Corporation Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 92. GeneScript Corporation Recent Development

Table 93. Yeastern Biotech Business Overview

Table 94. Yeastern Biotech Product

Table 95. Yeastern Biotech Company Details

Table 96. Yeastern Biotech Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 97. Yeastern Biotech Recent Development

Table 98. New England Biolabs Company Details

Table 99. New England Biolabs Business Overview

Table 100. New England Biolabs Product

Table 101. New England Biolabs Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 102. New England Biolabs Recent Development

Table 103. QIAGEN N.V. Company Details

Table 104. QIAGEN N.V. Business Overview

Table 105. QIAGEN N.V. Product

Table 106. QIAGEN N.V. Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 107. QIAGEN N.V. Recent Development

Table 108. OriGene Technologies Company Details

Table 109. OriGene Technologies Business Overview

Table 110. OriGene Technologies Product

Table 111. OriGene Technologies Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 112. OriGene Technologies Recent Development

Table 113. Lucigen Company Details

Table 114. Lucigen Business Overview

Table 115. Lucigen Product

Table 116. Lucigen Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 117. Lucigen Recent Development

Table 118. Zymo Research Company Details

Table 119. Zymo Research Business Overview

Table 120. Zymo Research Product

Table 121. Zymo Research Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 122. Zymo Research Recent Development

Table 123. Bio-Rad Laboratories Company Details

Table 124. Bio-Rad Laboratories Business Overview

Table 125. Bio-Rad Laboratories Product

Table 126. Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 127. Bio-Rad Laboratories Recent Development

Table 128. Bioline Company Details

Table 129. Bioline Business Overview

Table 130. Bioline Product

Table 131. Bioline Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 132. Bioline Recent Development

Table 133. Delphi Genetics Company Details

Table 134. Delphi Genetics Business Overview

Table 135. Delphi Genetics Product

Table 136. Delphi Genetics Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 137. Delphi Genetics Recent Development

Table 138. IBA GmBH Company Details

Table 139. IBA GmBH Business Overview

Table 140. IBA GmBH Product

Table 141. IBA GmBH Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 142. IBA GmBH Recent Development

Table 143. Cell Applications Company Details

Table 144. Cell Applications Business Overview

Table 145. Cell Applications Product

Table 146. Cell Applications Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 147. Cell Applications Recent Development

Table 148. BioDynamics Laboratory Company Details

Table 149. BioDynamics Laboratory Business Overview

Table 150. BioDynamics Laboratory Product

Table 151. BioDynamics Laboratory Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 152. BioDynamics Laboratory Recent Development

Table 153. Scarab Genomics Company Details

Table 154. Scarab Genomics Business Overview

Table 155. Scarab Genomics Product

Table 156. Scarab Genomics Revenue in Expression Competent Cells Business (2015-2020) (US$ Million)

Table 157. Scarab Genomics Recent Development

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Expression Competent Cells Market Share by Type: 2020 VS 2026

Figure 2. Chemically Competent Cells Features

Figure 3. Electrocompetent Cells Features

Figure 4. Global Expression Competent Cells Market Share by Application: 2020 VS 2026

Figure 5. Protein Expression Case Studies

Figure 6. Other Case Studies

Figure 7. Expression Competent Cells Report Years Considered

Figure 8. Global Expression Competent Cells Market Size (US$ Million), YoY Growth 2015-2026

Figure 9. Global Expression Competent Cells Market Share by Regions: 2020 VS 2026

Figure 10. Global Expression Competent Cells Market Share by Regions (2021-2026)

Figure 11. Global Expression Competent Cells Market Share by Players in 2019

Figure 12. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expression Competent Cells as of 2019

Figure 13. The Top 10 and 5 Players Market Share by Expression Competent Cells Revenue in 2019

Figure 14. North America Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 15. United States Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 16. Canada Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 17. Europe Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 18. Germany Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 19. France Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 20. U.K. Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 21. Italy Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 22. Russia Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 23. Nordic Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 24. Rest of Europe Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 25. Asia-Pacific Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 26. China Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 27. Japan Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 28. South Korea Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 29. Southeast Asia Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 30. India Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 31. Australia Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 32. Rest of Asia-Pacific Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 33. Latin America Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 34. Mexico Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 35. Brazil Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 36. Middle East & Africa Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 37. Turkey Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 38. Saudi Arabia Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 39. UAE Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 40. Rest of Middle East & Africa Expression Competent Cells Market Size YoY Growth (2015-2026) & (US$ Million)

Figure 41. Merck KGaA Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 42. Thermo Fisher Scientific Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 43. Agilent Technologies Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 44. Takara Bio Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 45. Promega Corporation Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 46. Beijing TransGen Biotech Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 47. GeneScript Corporation Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 48. Yeastern Biotech Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 49. New England Biolabs Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 50. QIAGEN N.V. Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 51. OriGene Technologies Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 52. Lucigen Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 53. Zymo Research Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 55. Bioline Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 56. Delphi Genetics Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 57. IBA GmBH Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 58. Cell Applications Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 59. BioDynamics Laboratory Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 60. Scarab Genomics Revenue Growth Rate in Expression Competent Cells Business (2015-2020)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

Merck KGaA

Thermo Fisher Scientific

Agilent Technologies

Takara Bio

Promega Corporation

Beijing TransGen Biotech

GeneScript Corporation

Yeastern Biotech

New England Biolabs

QIAGEN N.V.

OriGene Technologies

Lucigen

Zymo Research

Bio-Rad Laboratories

Bioline

Delphi Genetics

IBA GmBH

Cell Applications

BioDynamics Laboratory

Scarab Genomics

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase